Quest Diagnostics Incorporated
DGXDiagnostics & Research
$252.92+2.97%As of Oct 29vs prior close
- Market cap
- $27.9B
- P/E (TTM)
- 24.8×
- P/E (FY1)
- 22.4×
- From 52W high
- 0.00%
- EPS (LTM)
- $10.04
- Revenue (LTM)
- $11.8B
- Net margin
- 9.53%
- Dividend yield
- 1.34%
Nomior Score
76
Steady ProfileTop 4% of the scored universe
Growth42
Quality64
Value75
Momentum85
Resilience63
Growth
+4.84%revenue a year over 9 fiscal years
YE16 $7.2BLTM $11.8B
Connections
Revenue to profitQ3 YE26
10% of revenue became net profit, up 1 pt on a year.
Who owns it
6funds, 2 tracked portfolios